Free Radical Biology & Medicine, 21 (6)
Weeks 14: Initial Response Period During the first month, most patients notice appetite suppression and early gastrointestinal effects
In terms of side effects and tolerability, the advantage goes to neither (comparable)
This is the third Drug Safety-related Labeling Change (SrLC) since December 19, 2025, for the drug, according to the FDAs label change database
7 patients with migraine episodes and vasomotor headaches, chronic tinnitus and psychogenic pain attacks were studied, and after intravenous administration on 5 consecutive days followed by 5 injections every 48-72 h, DSIP lowered the pain levels of 6 out of 7 patients significantly
Common sites include the deltoid, vastus lateralis, and gluteal muscles